Not surprisingly, dysregulation of MCL-1 ubiquitylation and turn-over have been repeatedly associated with cancer and cancer chemoresistance (Schwickart et al., 2010; Wertz et al., 2011). The gene discussed is MCL1; the disease is cancer.